0000876661-16-001172.txt : 20160804
0000876661-16-001172.hdr.sgml : 20160804
20160804125804
ACCESSION NUMBER: 0000876661-16-001172
CONFORMED SUBMISSION TYPE: 25-NSE
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20160804
DATE AS OF CHANGE: 20160804
EFFECTIVENESS DATE: 20160804
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: China Nepstar Chain Drugstore Ltd.
CENTRAL INDEX KEY: 0001414850
STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33751
FILM NUMBER: 161806602
BUSINESS ADDRESS:
STREET 1: 6TH FLOOR, TOWER B, XINNENGYUAN BUILDING
STREET 2: NANHAI ROAD, NANSHAN DISTRICT
CITY: SHENZHEN
STATE: F4
ZIP: 518054
BUSINESS PHONE: 86-755-26433366
MAIL ADDRESS:
STREET 1: 6TH FLOOR, TOWER B, XINNENGYUAN BUILDING
STREET 2: NANHAI ROAD, NANSHAN DISTRICT
CITY: SHENZHEN
STATE: F4
ZIP: 518054
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NEW YORK STOCK EXCHANGE LLC
CENTRAL INDEX KEY: 0000876661
IRS NUMBER: 000000000
STATE OF INCORPORATION: NY
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
BUSINESS PHONE: 212-656-2060
MAIL ADDRESS:
STREET 1: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
FORMER COMPANY:
FORMER CONFORMED NAME: NEW YORK STOCK EXCHANGE INC
DATE OF NAME CHANGE: 19910628
25-NSE
1
primary_doc.xml
X0203
0000876661
NEW YORK STOCK EXCHANGE LLC
1414850
China Nepstar Chain Drugstore Ltd.
001-33751
6 F, Tower B, Xinnengyuan Building
Nanhai Road,Nanshan District
Shenzhen
518054
+(86)75526433366
American Depositary Shares (Each representing two Ordinary Shares)
17 CFR 240.12d2-2(a)(3)
Benjamin Sawyer
Manager
2016-08-04
EX-99.25
2
ruleprovisionnotice.htm
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES
The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on August 15, 2016, pursuant to the provisions of Rule 12d2-2 (a).
[ X ] 17 CFR 240.12d2-2(a)(3) That on August 3, 2016 the instruments representing the securities comprising the entire class of this security came to evidence, by operation of law or otherwise, other securities in substitution therefore and represent no other right except, if such be the fact, the right to receive an immediate cash payment.
The merger between China Nepstar Chain Drugstore Ltd. and Neptunus Global Limited, a direct wholly owned subsidiary of China Neptunus Drugstore Holding Ltd. became effective on August 3, 2016. Each American Depositary Share of China Nepstar Chain Drugstore, Ltd. was converted into $2.62 in cash.
The Exchange also notifies the Securities and Exchange Commission that as a result of the above indicated conditions this security was suspended from trading on August 4, 2016.